Entero Therapeutics (FRA:366) Other Long Term Assets : €0.03 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Entero Therapeutics Other Long Term Assets?

Entero Therapeutics's other long-term assets for the quarter that ended in Mar. 2024 was €0.03 Mil.

Entero Therapeutics's quarterly other long-term assets declined from Sep. 2023 (€0.03 Mil) to Dec. 2023 (€0.03 Mil) but then stayed the same from Dec. 2023 (€0.03 Mil) to Mar. 2024 (€0.03 Mil).

Entero Therapeutics's annual other long-term assets declined from Dec. 2021 (€0.04 Mil) to Dec. 2022 (€0.04 Mil) and declined from Dec. 2022 (€0.04 Mil) to Dec. 2023 (€0.03 Mil).

Entero Therapeutics Other Long Term Assets Historical Data

The historical data trend for Entero Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entero Therapeutics Other Long Term Assets Chart

Entero Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

0.04

0.02

0.04

0.03

Entero Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															0.04	0.03	0.03	0.03	0.03

Entero Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Entero Therapeutics (FRA:366) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entero Therapeutics Inc (FRA:366) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

ENTO:USA

Address

777 Yamato Road, Suite 502, Boca Raton, FL, USA, 33431

Website

https://www.firstwavebio.com

First Wave BioPharma Inc is a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases. It is advancing a therapeutic development pipeline populated with multiple clinical-stage programs built around its two proprietary technologies-niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients.

Entero Therapeutics (FRA:366) Headlines

No Headlines